- Home
- INO vs OFS Comparison
INO vs OFS Comparison
Compare INO & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INO
- OFS
- Stock Information
- Founded
- INO 1979
- OFS 2001
- Country
- INO United States
- OFS United States
- Employees
- INO 134
- OFS N/A
- Industry
- INO Medical/Dental Instruments
- OFS Finance/Investors Services
- Sector
- INO Health Care
- OFS Finance
- Exchange
- INO Nasdaq
- OFS Nasdaq
- Market Cap
- INO 128.1M
- OFS 117.0M
- IPO Year
- INO 1998
- OFS 2012
- Fundamental
- Price
- INO $2.37
- OFS $7.55
- Analyst Decision
- INO Buy
- OFS
- Analyst Count
- INO 5
- OFS 0
- Target Price
- INO $8.80
- OFS N/A
- AVG Volume (30 Days)
- INO 1.1M
- OFS 72.0K
- Earning Date
- INO 11-13-2025
- OFS 10-30-2025
- Dividend Yield
- INO N/A
- OFS 17.75%
- EPS Growth
- INO N/A
- OFS N/A
- EPS
- INO N/A
- OFS 0.76
- Revenue
- INO $182,337.00
- OFS $43,337,000.00
- Revenue This Year
- INO N/A
- OFS N/A
- Revenue Next Year
- INO $15,960.33
- OFS N/A
- P/E Ratio
- INO N/A
- OFS $10.02
- Revenue Growth
- INO N/A
- OFS N/A
- 52 Week Low
- INO $1.30
- OFS $7.52
- 52 Week High
- INO $5.83
- OFS $9.80
- Technical
- Relative Strength Index (RSI)
- INO 54.07
- OFS 27.87
- Support Level
- INO $2.38
- OFS $7.53
- Resistance Level
- INO $2.58
- OFS $7.81
- Average True Range (ATR)
- INO 0.14
- OFS 0.22
- MACD
- INO -0.03
- OFS -0.06
- Stochastic Oscillator
- INO 51.95
- OFS 2.82
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.